Dashboard
Manage Tickers

AMGNAMGEN INC

Nasdaq amgen.com


$ 310.84 $ 1.16 (0.37 %)    

Thursday, 09-May-2024 11:57:26 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 440.20 $ -0.26 (-0.06 %)
DIA $ 392.29 $ 2.18 (0.56 %)
SPY $ 518.54 $ 1.10 (0.21 %)
TLT $ 90.05 $ 0.00 (0 %)
GLD $ 215.49 $ 0.79 (0.37 %)
$ 307.31
$ 309.68
$ 307.57 x 100
$ 310.93 x 100
$ 306.37 - $ 311.02
$ 206.75 - $ 327.16
2,859,572
na
164.72B
$ 0.54
$ 43.77
TBD
na
na ($ 0.03)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-02-2024 03-31-2024 10-Q
2 02-14-2024 12-31-2023 10-K
3 10-31-2023 09-30-2023 10-Q
4 08-03-2023 06-30-2023 10-Q
5 04-28-2023 03-31-2023 10-Q
6 02-09-2023 12-31-2022 10-K
7 11-04-2022 09-30-2022 10-Q
8 08-04-2022 06-30-2022 10-Q
9 04-28-2022 03-31-2022 10-Q
10 02-16-2022 12-31-2021 10-K
11 11-03-2021 09-30-2021 10-Q
12 08-03-2021 06-30-2021 10-Q
13 04-28-2021 03-31-2021 10-Q
14 02-09-2021 12-31-2020 10-K
15 10-29-2020 09-30-2020 10-Q
16 07-29-2020 06-30-2020 10-Q
17 05-01-2020 03-31-2020 10-Q
18 02-12-2020 12-31-2019 10-K
19 10-30-2019 09-30-2019 10-Q
20 07-31-2019 06-30-2019 10-Q
21 05-01-2019 03-31-2019 10-Q
22 02-13-2019 12-31-2018 10-K
23 10-31-2018 09-30-2018 10-Q
24 07-27-2018 06-30-2018 10-Q
25 04-25-2018 03-31-2018 10-Q
26 02-13-2018 12-31-2017 10-K
27 10-26-2017 09-30-2017 10-Q
28 07-26-2017 06-30-2017 10-Q
29 04-27-2017 03-31-2017 10-Q
30 02-14-2017 12-31-2016 10-K
31 10-28-2016 09-30-2016 10-Q
32 07-29-2016 06-30-2016 10-Q
33 05-02-2016 03-31-2016 10-Q
34 02-16-2016 12-31-2015 10-K
35 11-02-2015 09-30-2015 10-Q
36 08-05-2015 06-30-2015 10-Q
37 04-27-2015 03-31-2015 10-Q
38 02-19-2015 12-31-2014 10-K
39 10-29-2014 09-30-2014 10-Q
40 08-05-2014 06-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

trade-desk-to-rally-around-28-here-are-10-top-analyst-forecasts-for-thursday
Trade Desk To Rally Around 28%? Here Are 1...
05/09/2024 12:28:25

mizuho-maintains-neutral-on-amgen-raises-price-target-to-235
Mizuho Maintains Neutral on Amgen, Raises ...
05/09/2024 11:48:45

Mizuho analyst Salim Syed maintains Amgen (NASDAQ:AMGN) with a Neutral and raises the price target from $223 to $235.

wall-street-stares-at-weaker-open-on-rate-anxiety-hopes-for-better-earnings-analyst-pencils-key-sp-500-support-level
Wall Street Stares At Weaker Open On Rate ...
05/09/2024 11:27:00

Trading in U.S. index futures suggests stocks may be off to a lackluster start again on Thursday.

market-whales-and-their-recent-bets-on-amgn-options
Market Whales and Their Recent Bets on AMG...
05/08/2024 16:01:15

how-is-the-market-feeling-about-amgen
How Is The Market Feeling About Amgen?
05/07/2024 18:45:14

spirit-airlines-posts-weak-results-joins-integra-lifesciences-bowlero-and-other-big-stocks-moving-lower-on-monday
Spirit Airlines Posts Weak Results, Joins ...
05/06/2024 17:05:12

amgen-ceo-robert-bradway-on-innovation-in-healthcare-says-hoping-to-have-innovation-approved-for-small-cell-lung-cancer-we-hope-to-help-rewrite-the-understanding-of-obesity-and-the-diseases-that-are-caused-by-it
Amgen CEO Robert Bradway, On Innovation In...
05/06/2024 16:31:21

- Milken Conference

check-out-what-whales-are-doing-with-amgn
Check Out What Whales Are Doing With AMGN
05/06/2024 14:17:38

cathie-woods-ark-invest-snaps-up-354m-worth-of-shares-in-this-biopharma-company-following-positive-obesity-pipeline-update
Cathie Wood's Ark Invest Snaps Up $3.54M W...
05/05/2024 19:16:25

As the demand for obesity drugs continues to surge, biopharma companies are eagerly seizing the opportunity to capitalize on th...

stocks-rally-as-jobs-report-rekindles-rate-cut-hopes-apple-rockets-bitcoin-soars-above-61000-whats-driving-markets-friday
Stocks Rally As Jobs Report Rekindles Rate...
05/03/2024 17:51:02

A weaker-than-expected jobs report sparked a widespread market rally in the last session of the week, as traders increased expe...

10-health-care-stocks-whale-activity-in-todays-session
10 Health Care Stocks Whale Activity In To...
05/03/2024 17:35:23

rbc-capital-maintains-outperform-on-amgen-lowers-price-target-to-328
RBC Capital Maintains Outperform on Amgen,...
05/03/2024 17:13:41

RBC Capital analyst Gregory Renza maintains Amgen (NASDAQ:AMGN) with a Outperform and lowers the price target from $332 to $...

morgan-stanley-maintains-equal-weight-on-amgen-raises-price-target-to-310
Morgan Stanley Maintains Equal-Weight on A...
05/03/2024 17:05:31

Morgan Stanley analyst Terence Flynn maintains Amgen (NASDAQ:AMGN) with a Equal-Weight and raises the price target from $271...

ubs-maintains-neutral-on-amgen-raises-price-target-to-307
UBS Maintains Neutral on Amgen, Raises Pri...
05/03/2024 15:59:43

UBS analyst Colin Bristow maintains Amgen (NASDAQ:AMGN) with a Neutral and raises the price target from $284 to $307.

william-blair-upgrades-amgen-to-outperform
William Blair Upgrades Amgen to Outperform
05/03/2024 15:55:24

William Blair analyst Matthew Phipps upgrades Amgen (NASDAQ:AMGN) from Market Perform to Outperform.

amgen-outlook-is-bright-analyst-predict-obesity-focused-drug-potential-will-drive-shareholder-value
Amgen Outlook Is Bright, Analyst Predict O...
05/03/2024 15:24:01

Amgen earnings beat estimates, and MariTide's promising Phase 2 results suggest significant differentiation from competitors.

bmo-capital-maintains-outperform-on-amgen-raises-price-target-to-355
BMO Capital Maintains Outperform on Amgen,...
05/03/2024 15:18:35

BMO Capital analyst Evan David Seigerman maintains Amgen (NASDAQ:AMGN) with a Outperform and raises the price target from $3...

wage-growth-slows--stock-market-celebrates-five-real-reasons-apple-is-running-up
Wage Growth Slows – Stock Market Celebrate...
05/03/2024 14:58:59

To gain an edge, this is what you need to know today.

amgen-posts-upbeat-results-joins-onespan-paylocity-holding-mercadolibre-and-other-big-stocks-moving-higher-on-friday
Amgen Posts Upbeat Results, Joins OneSpan,...
05/03/2024 14:15:59

barclays-upgrades-amgen-to-equal-weight-raises-price-target-to-300
Barclays Upgrades Amgen to Equal-Weight, R...
05/03/2024 14:10:27

Barclays analyst Carter Gould upgrades Amgen (NASDAQ:AMGN) from Underweight to Equal-Weight and raises the price target from...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION